Scholar Rock Holding SRRK
NASDAQ SRRK
$55.46 -0.48 (-0.86%)
As of: Sep 4, 2026 · 2:28 PM EDT

Scholar Rock Holding (SRRK) Other Working Capital Changes (2017 - 2026)

Scholar Rock Holding (SRRK) posted quarterly Other Working Capital Changes of -$1.4 million for Q1 2026, up 8.56% year-over-year from -$1.3 million in Q1 2025, and down 14.61% quarter-over-quarter from -$1.3 million in Q4 2025.

Analysis

Scholar Rock Holding (SRRK) Other Working Capital Changes (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Other Working Capital Changes history runs 9 years deep, the most recent figure standing at -$1.4 million for Q1 2026.

  • In Q1 2026, Other Working Capital Changes rose 8.56% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at -$5.6 million (up 7.25% YoY), while the FY2025 annual figure was -$5.8 million, up 7.93% from the prior year.
  • Other Working Capital Changes for Q1 2026 stood at -$1.4 million, down from -$1.3 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $7.0 million in Q1 2025, with the low at -$4.5 million in Q3 2022.
  • The 5-year median for Other Working Capital Changes is $36000.0 (2024), against an average of $429058.8.
  • Peak annual rise in Other Working Capital Changes reached 1626.02% in 2022, while the deepest fall reached 14984.75% in 2022.
  • Scholar Rock Holding's Other Working Capital Changes stood at $219000.0 in 2022, then plunged by 136.53% to -$80000.0 in 2023, then plunged by 1808.75% to -$1.5 million in 2024, then gained by 17.55% to -$1.3 million in 2025, then slipped by 14.61% to -$1.4 million in 2026.
  • Business Quant data shows SRRK's Other Working Capital Changes at -$1.4 million in Q1 2026, -$1.3 million in Q4 2025, and -$1.3 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Scholar Rock Holding 7.25 Bn 7.25 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.91 Mn
Jun 30, 2026 -4.91 Mn
Mar 31, 2026 2.04 Mn
Mar 31, 2026 2.04 Mn
Dec 31, 2025 -11.74 Mn
Dec 31, 2025 -11.74 Mn
Sep 30, 2025 -4.09 Mn
Sep 30, 2025 -4.09 Mn
Jun 30, 2025 3.08 Mn
Jun 30, 2025 3.08 Mn
Mar 31, 2025 6.97 Mn
Mar 31, 2025 6.97 Mn
Dec 31, 2024 -12.01 Mn
Dec 31, 2024 -12.01 Mn
Sep 30, 2024 9.01 Mn
Sep 30, 2024 9.01 Mn
Jun 30, 2024 -1.51 Mn
Jun 30, 2024 -1.51 Mn
Mar 31, 2024 -1.77 Mn
Mar 31, 2024 -1.77 Mn